Silicon Valley Bank provides new $10M credit facility to Solta Medical

Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide, added a new $10 million term loan to existing credit facilities for Solta Medical (Nasdaq: SLTM), a global leader in the medical aesthetics market. The additional term loan increases Solta Medical's credit facilities with Silicon Valley Bank to a total of $22 million. Solta Medical would expect to use the additional facility to pursue strategic initiatives.

"Silicon Valley Bank is an important partner in our continued success," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. "This additional financing will give us the flexibility we need to address potential growth opportunities."

"As a client of Silicon Valley Bank for nearly 10 years, we are pleased to continue to support Solta Medical with this latest credit facility," said Ben Colombo, senior relationship manager from Silicon Valley Bank. "We continue to focus on working with companies from their earliest stages through their growth into large, global corporations, while providing the right financial solutions all along the way. As Solta Medical continues to grow, we will seek to provide the best solutions to help meet the company's goals."

Silicon Valley Bank's experienced life science bankers offer a comprehensive suite of financing solutions, treasury management, corporate investment and international banking services to its clients worldwide.


Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aptamer extends agreement with genetic medicines customer